PHS
RVMD icon

PFM Health Sciences’s Revolution Medicines RVMD Stock Holding History

PFM Health Sciences’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.8M Buy
143,222
+2,452
+2% +$358K 2.3% 10
2026
Q1 		$13.7M Sell
140,770
-10,683
-7% -$1.08M 1.25% 24
2025
Q4 		$12.1M Sell
151,453
-179,616
-54% -$11.8M 1.2% 31
2025
Q3 		$15.5M Buy
+331,069
New +$13M 1.19% 29
2021
Q1 		– Sell
-209,116
Closed -$8.28M – 106
2020
Q4 		$8.28M Sell
209,116
-151,197
-42% -$5.98M 0.29% 73
2020
Q3 		$12.5M Buy
+360,313
New +$9.98M 0.58% 57

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

PFM Health Sciences's RVMD Position: Q2 2026 in Review

PFM Health Sciences increased its Revolution Medicines (RVMD) stake by 1.7% in Q2 2026, buying an estimated $358K and bringing the position to 143,222 shares worth $26.8M. The position accounts for 2.3% of the portfolio, ranked #10.

PFM Health Sciences first reported a position in RVMD in Q3 2020 and has held it in 6 quarters since. 691 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • PFM Health Sciences held 143,222 shares of Revolution Medicines worth $26.8M as of Q2 2026.
  • PFM Health Sciences bought 2,452 Revolution Medicines shares in Q2 2026, an estimated $358K.
  • Revolution Medicines made up 2.3% of PFM Health Sciences's portfolio in Q2 2026, its #10 holding.
  • PFM Health Sciences first reported a position in Revolution Medicines in Q3 2020 and has held it in 6 quarters since.
  • 691 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on PFM Health Sciences's 13F filing for Q2 2026, filed 14 Aug 2026.